Business Wire

TORONTO--(BUSINESS WIRE)-- Slate Office REIT (TSX: SOT.UN) (the "REIT"), an owner and operator of high-quality workplace real estate, reported today financial results and highlights for the three months ended March 31, 2024.

“Our team continued to drive steady leasing volumes across all of the REIT’s markets in the first quarter, converting interest and demand from high-quality credit tenants into new leases and renewals at positive leasing spreads and longer... (continue reading...)

DENVER--(BUSINESS WIRE)-- Gold Resource Corporation (NYSE American: GORO) (the “Company”) is pleased to announce its first quarter operational results from its Don David Gold Mine (“DDGM”) near Oaxaca, Mexico, and a corporate update on its other activities.

2024 Q1 Highlights include:

• Produced and sold 3,557 ounces of gold and 216,535 ounces of silver
• Produced and sold 1,682 tonnes of zinc, 264 tonnes of copper, and 667 tonnes of lead
• Cash balance... (continue reading...)

• Revenue: $202 million, 9% sequential increase
• Orders: $204 million and book-to-bill ratio of 101%
• Net loss: $10 million and diluted EPS of $0.85
• Adjusted EBITDA: $26 million, 69% sequential increase
• Operating cash flow and free cash flow: $5 million and $2 million, respectively
• Reaffirms full year 2024 guidance: $100 to $120 million in EBITDA and $40 to $60 million in free cash flow

HOUSTON--(BUSINESS WIRE)-- Forum Energy Technologies, Inc.... (continue reading...)

THOUSAND OAKS, Calif.--(BUSINESS WIRE)-- All amounts are in U.S. Dollars unless otherwise indicated:

2023 HIGHLIGHTS

• Adjusted EBITDA(1) was $39.1 million in 2023 compared to $25.1 million in 2022, an increase of 56%. This increase was due to the increase in production of 70% and lower realized losses from commodity contracts partially offset by a decrease in average prices of 22%
• Net revenues for 2023 were $50.6 million, an increase of 35% compared to 2022.... (continue reading...)

TEL AVIV, Israel--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the 2024 Bank of America Healthcare Conference on Tuesday, May 14, 2024. The presentation will begin at 8:40 A.M. Pacific Time (11:40 A.M. Eastern Time).

To access a live webcast of the presentation, visit Teva’s Investor Relations website at ... (continue reading...)